ORCHIDPHAR

Orchid Pharma Limited has informed the Exchange regarding 'Issue of 14,300 Zero coupon unsecured and non-marketable Optionally Convertible Debentures of Rs.1,00,000/- each pursuant to approved Resolution plan.'.

Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Orchid Pharma Limited has informed the Exchange about Credit Rating

Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Orchid Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (LODR) Regulations,2015'.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on September 07, 2020.

Orchid Pharma Limited has informed the Exchange about withdrawal of Credit Rating by CARE Ratings Limited

Orchid Pharma Limited has informed the Exchange regarding 'Secretarial compliance report for the year ended March 31,2020'.

Orchid Pharma Limited has informed the Exchange regarding 'Disclosure under Regulation 23(9) of SEBI (LODR) Regulations, 2015, for the half year ended on March 31, 2020'.

The Exchange has sought clarification from Orchid Pharma Limited for the quarter ended 31-Mar-2020 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Orchid Pharma Limited has informed the Exchange regarding 'Disclosure of material impact of COVID-19 on the company '.

Orchid Pharma Limited has informed the Exchange regarding 'Intimation under Regulation 30(5) of SEBI (LODR) Regualtions,2015'.

Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on Jun 29, 2020.

Promoters of Orchid Pharma Limited has informed the Exchange regarding disclosure under regulation 30(2) and 31(4) of SEBI (SAST) Regulations, 2011

Dhanuka Laboratories Limited has informed the Exchange regarding its Report under Regulation 10(6) of Securities and Exchange Board of India (SAST)Regulations, 2011

Orchid Pharma Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (LODR) Regulations,2015'.

Orchid Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.

Orchid Pharma Limited has informed the Exchange about implementation of the approved resolution plan

Orchid Pharma Limited has informed the Exchange regarding Newspaper advertisement of the Notice given to Shareholders for Record Date

Orchid Pharma Limited has informed the Exchange about

Intimation about trading window closure

Orchid Pharma Limited has informed the Exchange about implementation of the Approved resolution plan

Orchid Pharma Limited has informed the Exchange about appointment of Company Secretary and Compliance Officer

Corporate Insolvency Resolution Process-Updates

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on February 17, 2020.

Orchid Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on December 30, 2019

Orchid Pharma Limited has informed the Exchange regarding 'Dissolution of Shareholder, M/s Orchid Health Care Private Ltd, Promoter Group Company'.

Orchid Pharma Limited has informed the Exchange that Registrar of Companies, Chennai, order for extension of holding Annual General Meeting of the Company for the FY 2018-19.

Orchid Pharma Limited has informed the Exchange regarding Disclosure of Related Party Transaction under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Orchid Pharma Limited has informed the Exchange about

Orchid Pharma Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2019 to December 30, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on December 30, 2019.

Orchid Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on December 30, 2019

The Exchange has sought clarification from Orchid Pharma Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.

Orchid Pharma Limited has informed the Exchange about

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2019.

K Raghavendra Rao has informed the Exchange regarding reason for encumbrance vide letter dated October 18, 2019 under SEBI ( SAST) Regulations, 2011.

The Exchange has sought clarification from Orchid Pharma Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.

Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on August 12, 2019.

Orchid Pharma Limited has informed the Exchange regarding 'NATIONAL COMPANY LAW APPELLATE TRIBUNAL ORDER 26.07.2019'.

Orchid Pharma Limited has informed the Exchange that the trading in Equity Shares of Orchid Pharma Limited shall be suspended w.e.f. July 25, 2019 (i.e. closing hours of trading on July 24, 2019) on account of Reduction of Share Capital.

Orchid Pharma Limited has informed the Exchange that the Company has fixed Record Date as July 27, 2019 for the purpose of Reduction of share capital

Orchid Pharma Limited has informed the Exchange about Updates on Corporate Insolvency Resolution Process

Orchid Pharma Limited has informed the Exchange about updates on Corporate Insolvency Resolution Process